Comparing biologicals for severe chronic rhinosinusitis with nasal polyps: A network meta-analysis

Autores da FMUP

• Diana Margarida Gonçalves Solha Pereira Da Silva

  Autor

• Bernardo Manuel De Sousa Pinto

  Autor

• José Luís Dias Delgado

  Autor

Participantes de fora da FMUP

• Boechat, JL

Unidades de investigação

• Laboratório Associado RISE- Rede de Investigação em Saúde

  

  Investigador

  Fernando Carlos De Landér Schmitt

• Medicina da Comunidade, Informação e Decisão em Saúde

• Patologia

• RISE-Health

  

  Investigador

  Fernando Carlos De Landér Schmitt

Abstract

[No abstract available]

Keywords

• Biological Products; Chronic Disease; Humans; Nasal Polyps; Network Meta-Analysis; Rhinitis; Sinusitis; benralizumab; dupilumab; immunoglobulin E; mepolizumab; omalizumab; placebo; steroid; biological product; asthma; chronic rhinosinusitis; disease severity; drug efficacy; drug safety; eosinophil; human; immunoglobulin blood level; Letter; meta analysis; minimal clinically important difference; nasal polyp score; network meta-analysis; nose polyp; odor recognition test; outcome assessment; patient history of surgery; randomized controlled trial (topic); scoring system; sino-nasal outcome test-22; systematic review; treatment duration; university of pennsylvania smell identification test score; chronic disease; complication; network meta-analysis; nose polyp; rhinitis; sinusitis